Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Munker

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2011
Update on desmoid tumorsC Escobar, R Munker, J O Thomas, et al.
Acta Haematologica|January 1, 1993
Effects of tumor necrosis-factor on primary human leukemia cells: ultrastructural changesR Munker, L Greither, M Darsow, et al.
Hematology and Cell Therapy|April 1, 1997
Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killingR Munker, F Marini, S Jiang, et al.
Blood|July 1, 1987
Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factorH P Koeffler, J Gasson, J Ranyard, et al.
Acta Haematologica|April 29, 1998
Phase I study of taxol in refractory acute myelogenous leukemias using a weekly scheduleR Munker, H Kantarjian, S O'Brien, et al.
AJR. American Journal of Roentgenology|October 1, 1996
Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival ratesA Stäbler, A Baur, R Bartl, et al.
Leukemia Research|October 23, 1998
Further characterization of cyclophosphamide resistance: expression of CD95 and of bcl-2 in a CML cell lineR Munker, S Zhao, S Jiang, et al.
The Journal of Dermatologic Surgery and Oncology|April 1, 1984
Cells reactive with anti-T-cell monoclonal antibodies in malignant cutaneous B-cell lymphomas and pseudolymphomasP Kaudewitz, G Burg, K Klepzig, et al.
Onkologie|January 19, 2002
Advanced head and neck cancer: long-term results of chemo-radiotherapy, complications and induction of second malignanciesR Munker, L Purmale, U Aydemir, et al.
Clinical and Experimental Immunology|November 1, 1984
The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigenH W Ziegler-Heitbrock, A Fütterer, H Rumpold, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2011
Update on desmoid tumorsC Escobar, R Munker, J O Thomas, et al.
Acta Haematologica|January 1, 1993
Effects of tumor necrosis-factor on primary human leukemia cells: ultrastructural changesR Munker, L Greither, M Darsow, et al.
Hematology and Cell Therapy|April 1, 1997
Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killingR Munker, F Marini, S Jiang, et al.
Blood|July 1, 1987
Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factorH P Koeffler, J Gasson, J Ranyard, et al.
Acta Haematologica|April 29, 1998
Phase I study of taxol in refractory acute myelogenous leukemias using a weekly scheduleR Munker, H Kantarjian, S O'Brien, et al.
AJR. American Journal of Roentgenology|October 1, 1996
Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival ratesA Stäbler, A Baur, R Bartl, et al.
Leukemia Research|October 23, 1998
Further characterization of cyclophosphamide resistance: expression of CD95 and of bcl-2 in a CML cell lineR Munker, S Zhao, S Jiang, et al.
The Journal of Dermatologic Surgery and Oncology|April 1, 1984
Cells reactive with anti-T-cell monoclonal antibodies in malignant cutaneous B-cell lymphomas and pseudolymphomasP Kaudewitz, G Burg, K Klepzig, et al.
Onkologie|January 19, 2002
Advanced head and neck cancer: long-term results of chemo-radiotherapy, complications and induction of second malignanciesR Munker, L Purmale, U Aydemir, et al.
Clinical and Experimental Immunology|November 1, 1984
The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigenH W Ziegler-Heitbrock, A Fütterer, H Rumpold, et al.
Pageof 9